|
| leghisturl = http://thomas.loc.gov/cgi-bin/bdquery/z?d107:HR04013:@@@R | introducedin = House | introducedbill = | introducedby = John Shimkus (R-IL) | introduceddate = March 20, 2002 | committees = House Energy and Commerce | passedbody1 = House | passeddate1 = October 1, 2002 | passedvote1 = Agreed voice vote | passedbody2 = Senate | passedas2 = | passeddate2 = October 17, 2002 | passedvote2 = Passed unanimous consent | conferencedate = | passedbody3 = | passeddate3 = | passedvote3 = | agreedbody3 = | agreeddate3 = | agreedvote3 = | agreedbody4 = | agreeddate4 = | agreedvote4 = | passedbody4 = | passeddate4 = | passedvote4 = | signedpresident = George W. Bush | signeddate = November 6, 2002 | unsignedpresident = | unsigneddate = | vetoedpresident = | vetoeddate = | overriddenbody1 = | overriddendate1 = | overriddenvote1 = | overriddenbody2 = | overriddendate2 = | overriddenvote2 = | amendments = | SCOTUS cases = }} The Rare Disease Act of 2002 is a law passed in the United States that establishes the statutory authorization for the Office of Rare Diseases as a federal entity able to recommend a national research agenda, coordinate research, and provide educational activities for researchers. ==Background== A rare disease or disorder is defined in the U.S. as one affecting fewer than 200,000 Americans. There are more than 6,000 known rare diseases, and it is estimated that about 25 million Americans are affected by them (as of 2002). Prior to the RDA was the Orphan Drug Act of 1983 which was designed to facilitate the development and commercialization of drugs to treat rare diseases, termed ''orphan drugs''. This act however did not provide for the creation of a centralized structure able to coordinate research or recommend agendas that would better facilitate research and education. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Rare Diseases Act of 2002」の詳細全文を読む スポンサード リンク
|